What's the Link Between Theory of Mind and Other Cognitive Abilities - A Co-twin Control Design of Neurodevelopmental Disorders

What’s the Link Between Theory of Mind and Other Cognitive Abilities – A Co-twin Control Design of Neurodevelopmental Disorders

Theory of thoughts (ToM), or the capacity to attribute psychological states to oneself and others, is a core factor of social cognition (SC). Even although its significance for social functioning usually, and neurodevelopmental problems (NDDs), specifically, is nicely established, the hyperlinks between ToM and different cognitive features usually are not. Especially the familial underpinnings of such hyperlinks stay unclear.
Using a co-twin management design, we examined N = 311 twins (imply age M = 17.19 years, 47% females) recognized with autism spectrum dysfunction (ASD), consideration-deficit/hyperactivity dysfunction (ADHD), different NDDs, or sometimes growing people. We used the Reading the Mind in the Eyes Test to operationalize ToM, the Fragmented Pictures Test for central coherence (CC), the Tower Test for govt functioning (EF), and the normal capacity index in the Wechsler Intelligence Scales for IQ.
In the linear regressions, weak CC and a decrease IQ have been related to a decreased ToM capacity throughout pairs. Female intercourse and larger age have been robustly related to elevated ToM capacity, whereas EF was not related to ToM. In the inside-pair analyses, the place unmeasured familial confounders are implicitly adjusted, the associations between ToM and different cognitive features, have been attenuated and the affiliation with CC was non-important.
The end result means that familial elements shared by the twins, reminiscent of genetic and shared setting, affect the affiliation between CC, IQ, and ToM. Future research want to incorporate a bigger pattern of monozygotic twins, who’re genetically similar, with the intention to draw extra agency conclusions relating to the affect of familial elements, and to distinguish between shared environmental and genetic results on the associations between cognitive features.

Safety and Efficacy of Intravenous Ferric Derisomaltose Compared to Iron Sucrose for Iron Deficiency Anemia in Patients with Chronic Kidney Disease With and Without Heart Failure

Ferric derisomaltose (FDI) is an intravenous (IV) excessive-dose iron formulation authorised in the US for the remedy of iron deficiency anemia in adults who’re illiberal of/have had an unsatisfactory response to oral iron, or who’ve non-dialysis-dependent continual kidney illness (NDD-CKD). FERWON-NEPHRO was a randomized, open-label, multicenter scientific trial evaluating the security and efficacy of a single infusion of FDI 1,000 mg versus as much as 5 doses of iron sucrose (IS) 200 mg (advisable cumulative dose, 1,000 mg) over eight weeks in sufferers with NDD-CKD and iron deficiency anemia. Of 1,525 sufferers included in the security evaluation, 244 (16%) had a historical past of coronary heart failure (HF).
Overall, the price of critical or extreme hypersensitivity reactions was low and didn’t differ between remedy teams. Cardiovascular hostile occasions (AEs) have been reported for 9.4% of sufferers who had HF and 4.2% who didn’t. Time to first cardiovascular AE was longer following administration of FDI in contrast with IS (hazard ratio: 0.59 [95% CI: 0.37, 0.92]; p=0.0185), a distinction that was comparable in sufferers with or with out HF (p=0.908 for interplay).
 What's the Link Between Theory of Mind and Other Cognitive Abilities - A Co-twin Control Design of Neurodevelopmental Disorders
Patients achieved a sooner hematological response (assessed by adjustments in hemoglobin and ferritin concentrations, and improve in transferrin saturation) with FDI versus IS. In conclusion, in sufferers with NDD-CKD, a single infusion of FDI was secure, nicely tolerated, and was related to fewer cardiovascular AEs and a sooner hematological response, in comparison with a number of doses of IS. These results have been comparable for sufferers with and with out HF.

Further proof for de novo variants in SYNCRIP as the trigger of a neurodevelopmental dysfunction

SYNCRIP encodes for the Synaptotagmin-binding cytoplasmic RNA-interacting protein, concerned in RNA-binding and regulation of a number of mobile pathways. It has been proposed as a candidate gene for neurodevelopmental problems (NDDs) with autism spectrum dysfunction (ASD), mental incapacity (ID), and epilepsy. We ascertained genetic, scientific, and neuroradiological information of three further people with novel de novo SYNCRIP variants.
All people had ID. Autistic options have been noticed in two. One particular person confirmed myoclonic-atonic epilepsy. Neuroradiological options comprised periventricular nodular heterotopia and widening of subarachnoid areas. Two frameshift variants in the extra severely affected people, seemingly end in haploinsufficiency.
The third missense variant lies in the conserved RRM 2 area seemingly affecting RNA-binding. Our findings assist the significance of RRM domains for SYNCRIP performance and counsel genotype-phenotype correlations. Our research supplies additional proof for an SYNCRIP-related NDD characterised by ID and ASD sporadically accompanied by malformations of cortical growth and myoclonic-atonic epilepsy.
Check This One: Rat Tumor Necrosis Factor (TNF) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Rat Tumor Necrosis Factor (TNF) concentrations in serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. Get More Information: abx050220

Neurodegenerative Disease Risk in Carriers of Autosomal Recessive Disease

Genetics has pushed important discoveries in the area of neurodegenerative illnesses (NDDs). An rising theme in neurodegeneration warrants an pressing and complete replace: that provider standing of early-onset autosomal recessive (AR) illness, sometimes thought-about benign, is related to an elevated threat of a spectrum of late-onset NDDs.
Glucosylceramidase beta (GBA1) gene mutations, liable for the AR lysosomal storage dysfunction Gaucher illness, are a outstanding instance of this precept, having been recognized as an necessary genetic threat issue for Parkinson illness. Genetic analyses have revealed additional examples, notably GRN, TREM2, EIF2AK3, and a number of different LSD and mitochondria perform genes.

DcR2 Antibody

MBS9411384-01mL MyBiosource 0.1mL 495 EUR

DcR2 Antibody

MBS9411384-5x01mL MyBiosource 5x0.1mL 2075 EUR

DcR2 Antibody

MBS8506050-01mL MyBiosource 0.1mL 325 EUR

DcR2 Antibody

MBS8506050-01mLAF405L MyBiosource 0.1mL(AF405L) 565 EUR

DcR2 Antibody

MBS8506050-01mLAF405S MyBiosource 0.1mL(AF405S) 565 EUR

DcR2 Antibody

MBS8506050-01mLAF610 MyBiosource 0.1mL(AF610) 565 EUR

DcR2 Antibody

MBS8506050-01mLAF635 MyBiosource 0.1mL(AF635) 565 EUR

DcR2 Antibody

MBS853411-01mg MyBiosource 0.1mg 345 EUR

DcR2 Antibody

MBS853411-01mLAF405L MyBiosource 0.1mL(AF405L) 565 EUR

DcR2 Antibody

MBS853411-01mLAF405S MyBiosource 0.1mL(AF405S) 565 EUR

DcR2 Antibody

MBS853411-01mLAF610 MyBiosource 0.1mL(AF610) 565 EUR

DcR2 Antibody

MBS853411-01mLAF635 MyBiosource 0.1mL(AF635) 565 EUR

DcR2 Antibody

MBS151536-01mg MyBiosource 0.1mg 445 EUR

DcR2 Antibody

MBS151536-5x01mg MyBiosource 5x0.1mg 1965 EUR

Rabbit Polyclonal DcR2 Antibody

TA305975 Origene Technologies GmbH 100 µg Ask for price

DcR2 Rabbit Monoclonal Antibody

E10G21303 EnoGene 100 μl 275 EUR
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

DcR2 (TNFRSF10D) goat polyclonal antibody

GT15063-100 Origene Technologies GmbH 100 µg Ask for price

Human DcR2/TRAIL R4 Antibody Pair Set

ABPR-ZB173 Creative Diagnostics 5 plates, 15 plates Ask for price
Description: Quantitative determination of Human DcR2/TRAIL R4

Mouse Anti-Human DcR2/TRAIL R4 monoclonal antibody, clone NN19

CABT-ZB595 Creative Diagnostics 50 μl 456 EUR
Description: Mouse

Mouse Anti-Human DcR2/TRAIL R4 monoclonal antibody, clone NN10

CABT-ZB947 Creative Diagnostics 50 μl 456 EUR
Description: Mouse

DcR2 (TNFRSF10D) rabbit polyclonal antibody, Purified

SP1174P Origene Technologies GmbH 100 µg Ask for price

DcR2/TRAIL R4 Matched ELISA Antibody Pair Set, Human

MBS8118246-15Plates MyBiosource 15Plates 800 EUR

DcR2/TRAIL R4 Matched ELISA Antibody Pair Set, Human

MBS8118246-5Plates MyBiosource 5Plates 450 EUR

DcR2/TRAIL R4 Matched ELISA Antibody Pair Set, Human

MBS8118246-5x15Plates MyBiosource 5x15Plates 3695 EUR

DcR2 (TNFRSF10D) (Center) rabbit polyclonal antibody, Aff - Purified

AP54308PU-N Origene Technologies GmbH 400 µl Ask for price

DcR2 (TNFRSF10D) mouse monoclonal antibody, clone B-R27, PE

AM31202RP-N Origene Technologies GmbH 1 ml (100 Tests) Ask for price

DcR2 (TNFRSF10D) mouse monoclonal antibody, clone B-R27, Purified

AM31202PU-N Origene Technologies GmbH 2 ml (200 Tests) Ask for price

Rabbit anti-Saccharomyces cerevisiae (strain ATCC 204508/S288c)(Baker's yeast) DCR2 Polyclonal Antibody

MBS9017504-INQUIRE MyBiosource INQUIRE Ask for price

DcR2 Peptide

2021P ProSci 0.05 mg 197.7 EUR
Description: (ID) DcR2 peptide

DcR2 Peptide

MBS152842-005mg MyBiosource 0.05mg 175 EUR

DcR2 Peptide

MBS152842-5x005mg MyBiosource 5x0.05mg 770 EUR

DcR2 (TNFRSF10D) mouse monoclonal antibody, clone TRAIL-R4-01, PE

AM03039RP-N Origene Technologies GmbH 100 µg Ask for price

DcR2 (TNFRSF10D) mouse monoclonal antibody, clone B-P30, Azide Free

AM31201AF-N Origene Technologies GmbH 200 µg Ask for price

DcR2 (TNFRSF10D) mouse monoclonal antibody, clone TRAIL-R4-01, FITC

AM03039FC-N Origene Technologies GmbH 100 µg Ask for price

DcR2 (TNFRSF10D) mouse monoclonal antibody, clone TRAIL-R4-01, Azide Free

AM03039AF-N Origene Technologies GmbH 100 µg Ask for price

Anti-DcR2 Antibody

Y080031 ABM 100 µl 125 EUR

Anti-DcR2 Antibody

2419 Genovis AB 100ug 445 EUR

Anti-DcR2 Antibody

MBS194060-01mg MyBiosource 0.1mg 495 EUR

Anti-DcR2 Antibody

MBS194060-5x01mg MyBiosource 5x0.1mg 2215 EUR

Anti-DcR2 antibody

PAab02271 Nova Lifetech 100ug 300 EUR

DCR2 Rabbit mAb

60008 SAB 100ul 339 EUR

DcR2 Rabbit mAb

E2R24086 EnoGene 100ul 255 EUR
Description: Available in various conjugation types.

DcR2 Rabbit mAb

52249 SAB 100ul 499 EUR

DCR2 Rabbit mAb

A3581 Abclonal 100μL 778.7 EUR
Description: Recombinant fusion protein containing a sequence corresponding to amino acids 1-165 of human RPL7A (P62424).

DcR2 Rabbit mAb

E2R389166 EnoGene 100ul 275 EUR
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

DcR2 Rabbit mAb

MBS4752697-01mL MyBiosource 0.1mL 450 EUR

DcR2 Rabbit mAb

MBS4752697-5x01mL MyBiosource 5x0.1mL 1540 EUR

DcR2 Rabbit mAb

MBS9466962-005mL MyBiosource 0.05mL 290 EUR

DcR2 Rabbit mAb

MBS9466962-01mL MyBiosource 0.1mL 435 EUR

DcR2 Rabbit mAb

MBS9466962-5x01mL MyBiosource 5x0.1mL 1810 EUR

Human DcR2 ELISA KIT

EF009028 Nova Lifetech 96tests 566 EUR

Anti-DcR2 TNFRSF10D Antibody

A05136-1 BosterBio 0.1mg 449 EUR
Description: Boster Bio Anti-DcR2 TNFRSF10D Antibody (Catalog # A05136-1). Tested in ELISA, WB, ICC, IHC-P, IF applications. This antibody reacts with Human, Mouse, Rat.

Recombinant Human DcR2 Protein

MBS9141853-002mg MyBiosource 0.02mg 165 EUR

Recombinant Human DcR2 Protein

MBS9141853-005mg MyBiosource 0.05mg 195 EUR

Recombinant Human DcR2 Protein

MBS9141853-01mg MyBiosource 0.1mg 250 EUR

Recombinant Human DcR2 Protein

MBS9141853-5x01mg MyBiosource 5x0.1mg 945 EUR

Anti-DCR2 Rabbit Monoclonal Antibody

M05136-2 BosterBio 30ul 154 EUR
Description: WB 1:500-1:2000;IHC 1:50-1:200;ICC/IF 1:50-1:200

human Trail Receptor 4/DcR2/CD264

M850850048 Tecan Benelux 1 unit 267.03 EUR

Human DCR2/TNFRSF10D PicoKine ELISA Kit

EK2067 BosterBio 96 wells 510 EUR
Description: For quantitative detection of human DCR2/TNFRSF10D in cell culture supernates, serum and plasma (heparin, EDTA, citrate).

Human DCR2/TNFRSF10D PicoKine ELISA Kit

MBS1752672-5x96StripWells MyBiosource 5x96-Strip-Wells 2755 EUR

Human DCR2/TNFRSF10D PicoKine ELISA Kit

MBS1752672-96StripWells MyBiosource 96-Strip-Wells 600 EUR

Human DcR2 (Decoy receptor 2) ELISA Kit

MBS7615303-10x96StripWells MyBiosource 10x96-Strip-Wells 3900 EUR

Human DcR2 (Decoy receptor 2) ELISA Kit

MBS7615303-48StripWells MyBiosource 48-Strip-Wells 340 EUR

Human DcR2 (Decoy receptor 2) ELISA Kit

MBS7615303-5x96StripWells MyBiosource 5x96-Strip-Wells 2045 EUR

Human DcR2 (Decoy receptor 2) ELISA Kit

MBS7615303-96StripWells MyBiosource 96-Strip-Wells 455 EUR

Anti-B. anthracis Protective Antigen Monoclonal antibody, Clone DCR0203

DMABT-Z59226 Creative Diagnostics 1 mg 926.1 EUR
Description: Mouse

anti-DcR2

YF-PA25185 Abfrontier 50 ul 400.8 EUR
Description: Mouse polyclonal to DcR2

Recombinant Human DcR2 Protein, Fc & His Tag

E40KMP1006 EnoGene 20ug 495 EUR

DcR2 (TNFRSF10D) (NM_003840) Human Over-expression Lysate

LS008793 BosterBio 100ug 628 EUR
Description: Transient overexpression lysate of tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain (TNFRSF10D)

Human DcR2/TRAIL R4 HEK293 Overexpression Lysate

MBS8113831-03mg MyBiosource 0.3mg 280 EUR

Human DcR2/TRAIL R4 HEK293 Overexpression Lysate

MBS8113831-5x03mg MyBiosource 5x0.3mg 1205 EUR

Human DcR2/TRAIL R4 HEK293 Overexpression Lysate

MBS8113833-03mg MyBiosource 0.3mg 280 EUR

Human DcR2/TRAIL R4 HEK293 Overexpression Lysate

MBS8113833-5x03mg MyBiosource 5x0.3mg 1205 EUR

Rhesus DcR2/TRAIL R4 HEK293 Overexpression Lysate

MBS8117808-03mg MyBiosource 0.3mg 280 EUR

Rhesus DcR2/TRAIL R4 HEK293 Overexpression Lysate

MBS8117808-5x03mg MyBiosource 5x0.3mg 1205 EUR

Rhesus DcR2/TRAIL R4 HEK293 Overexpression Lysate

MBS8117809-03mg MyBiosource 0.3mg 280 EUR

Rhesus DcR2/TRAIL R4 HEK293 Overexpression Lysate

MBS8117809-5x03mg MyBiosource 5x0.3mg 1205 EUR

DcR2/TRAIL R4 Protein, Human, Recombinant (His Tag)

MBS8118629-01mg MyBiosource 0.1mg 290 EUR

DcR2/TRAIL R4 Protein, Human, Recombinant (His Tag)

MBS8118629-1mg MyBiosource 1mg 1465 EUR

DcR2/TRAIL R4 Protein, Human, Recombinant (His Tag)

MBS8118629-5x1mg MyBiosource 5x1mg 6445 EUR

DcR2/TRAIL R4 Protein, Rhesus, Recombinant (hFc Tag)

MBS8123548-01mg MyBiosource 0.1mg 290 EUR

DcR2/TRAIL R4 Protein, Rhesus, Recombinant (hFc Tag)

MBS8123548-5x01mg MyBiosource 5x0.1mg 1155 EUR

DcR2/TRAIL R4 Protein, Rhesus, Recombinant (His Tag)

MBS8123549-01mg MyBiosource 0.1mg 395 EUR

DcR2/TRAIL R4 Protein, Rhesus, Recombinant (His Tag)

MBS8123549-1mg MyBiosource 1mg 2175 EUR

DcR2/TRAIL R4 Protein, Rhesus, Recombinant (His Tag)

MBS8123549-5x1mg MyBiosource 5x1mg 9625 EUR

Anti-DcR2/TRAIL R4 Antibody, Mouse Monoclonal

MBS8102707-01mL MyBiosource 0.1mL 300 EUR

Anti-DcR2/TRAIL R4 Antibody, Mouse Monoclonal

MBS8102707-5x01mL MyBiosource 5x0.1mL 1200 EUR

Anti-DcR2/TRAIL R4 Antibody, Mouse Monoclonal

MBS8102708-01mL MyBiosource 0.1mL 300 EUR

Anti-DcR2/TRAIL R4 Antibody, Mouse Monoclonal

MBS8102708-5x01mL MyBiosource 5x0.1mL 1200 EUR

Anti-DcR2/TRAIL R4 Antibody, Mouse Monoclonal

MBS8102709-01mL MyBiosource 0.1mL 300 EUR

Anti-DcR2/TRAIL R4 Antibody, Mouse Monoclonal

MBS8102709-5x01mL MyBiosource 5x0.1mL 1200 EUR

Anti-DcR2/TRAIL R4 Antibody, Rabbit Polyclonal

MBS8102714-01mL MyBiosource 0.1mL 300 EUR

Anti-DcR2/TRAIL R4 Antibody, Rabbit Polyclonal

MBS8102714-5x01mL MyBiosource 5x0.1mL 1200 EUR

Anti-DcR2/TRAIL R4 Antibody, Rabbit Polyclonal

MBS8102716-01mL MyBiosource 0.1mL 300 EUR

Anti-DcR2/TRAIL R4 Antibody, Rabbit Polyclonal

MBS8102716-5x01mL MyBiosource 5x0.1mL 1200 EUR

Anti-DcR2/TRAIL R4 Antibody, Rabbit Polyclonal

MBS8102717-01mL MyBiosource 0.1mL 300 EUR

Anti-DcR2/TRAIL R4 Antibody, Rabbit Polyclonal

MBS8102717-5x01mL MyBiosource 5x0.1mL 1200 EUR

Anti-DcR2/TRAIL R4 Antibody, Rabbit Polyclonal

MBS8113193-01mL MyBiosource 0.1mL 300 EUR

Anti-DcR2/TRAIL R4 Antibody, Rabbit Polyclonal

MBS8113193-5x01mL MyBiosource 5x0.1mL 1200 EUR

Anti-DcR2/TRAIL R4 Antibody, Rabbit Polyclonal

MBS8113194-01mL MyBiosource 0.1mL 300 EUR

Anti-DcR2/TRAIL R4 Antibody, Rabbit Polyclonal

MBS8113194-5x01mL MyBiosource 5x0.1mL 1200 EUR

human Trail Receptor 4/DcR2/CD264 1 x 96

M850850096 Tecan Benelux 1 unit 492.85 EUR

human Trail Receptor 4/DcR2/CD264 2 x 96

M850850192 Tecan Benelux 1 unit 791.27 EUR

TNFRSF6B/DCR3 Rabbit anti-Human Polyclonal Antibody

MBS2402673-005mL MyBiosource 0.05mL 615 EUR

TNFRSF6B/DCR3 Rabbit anti-Human Polyclonal Antibody

MBS2402673-5x005mL MyBiosource 5x0.05mL 2605 EUR

DcR2/TRAIL R4 Protein, Human, Recombinant (ECD, hFc Tag)

MBS8120254-01mg MyBiosource 0.1mg 290 EUR

DcR2/TRAIL R4 Protein, Human, Recombinant (ECD, hFc Tag)

MBS8120254-5x01mg MyBiosource 5x0.1mg 1155 EUR

DcR3 Antibody

2140-002mg ProSci 0.02 mg 206.18 EUR
Description: DcR3 Antibody: Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors. Several novel members in the TNFR family including DR3, DR4, DR5, and DR6 were recently discovered and function as cell death receptors. Two decoy receptors, DcR1 and DcR2, were recently identified to compete with DR4 and DR5 for their ligand TRAIL binding. A novel decoy receptor was more recently discovered and designated DcR3 and TR6, respectively,. Unlike DcR1 and DcR2, DcR3 is a soluble rather than a membrane associated molecule. DcR3 binds to FasL and LIGHT and inhibits FasL and LIGHT induced apoptosis. DcR3 transcript is expressed in a number of lung and colon carcinomas and in some normal tissues.

DcR3 Antibody

2140-01mg ProSci 0.1 mg 523.7 EUR
Description: DcR3 Antibody: Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors. Several novel members in the TNFR family including DR3, DR4, DR5, and DR6 were recently discovered and function as cell death receptors. Two decoy receptors, DcR1 and DcR2, were recently identified to compete with DR4 and DR5 for their ligand TRAIL binding. A novel decoy receptor was more recently discovered and designated DcR3 and TR6, respectively,. Unlike DcR1 and DcR2, DcR3 is a soluble rather than a membrane associated molecule. DcR3 binds to FasL and LIGHT and inhibits FasL and LIGHT induced apoptosis. DcR3 transcript is expressed in a number of lung and colon carcinomas and in some normal tissues.

DcR1 Antibody

2179-002mg ProSci 0.02 mg 206.18 EUR
Description: DcR1 Antibody: Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors. TRAIL/Apo2L is a new member of the TNF family and induces apoptosis of a variety of tumor cell lines. DR4 and DR5 are the recently identified functional receptors for TRAIL. Two decoy receptors for TRAIL have been identified and designated DcR1/TRID/TRAIL-R3/LIT and DcR2/TRAIL-R4/TRUNDD. DcR1 has extracellular TRAIL-binding domain but lacks intracellular signaling domain. It is a glycophospholipid-anchored cell surface protein. DcR1 transcripts were expressed in many normal human tissues but not in most cancer cell lines. Overexpression of DcR1 did not induce apoptosis, but attenuated TRAIL-induced apoptosis.

DcR1 Antibody

2179-01mg ProSci 0.1 mg 523.7 EUR
Description: DcR1 Antibody: Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors. TRAIL/Apo2L is a new member of the TNF family and induces apoptosis of a variety of tumor cell lines. DR4 and DR5 are the recently identified functional receptors for TRAIL. Two decoy receptors for TRAIL have been identified and designated DcR1/TRID/TRAIL-R3/LIT and DcR2/TRAIL-R4/TRUNDD. DcR1 has extracellular TRAIL-binding domain but lacks intracellular signaling domain. It is a glycophospholipid-anchored cell surface protein. DcR1 transcripts were expressed in many normal human tissues but not in most cancer cell lines. Overexpression of DcR1 did not induce apoptosis, but attenuated TRAIL-induced apoptosis.

DcR3 Antibody

24071 SAB 100ul 479 EUR

DcR3 Antibody

24071-100ul SAB 100ul 468 EUR

DcR1 Antibody

24079 SAB 100ul 479 EUR

DcR1 Antibody

24079-100ul SAB 100ul 468 EUR

DcR1 Antibody

24113 SAB 100ul 479 EUR

DcR1 Antibody

24113-100ul SAB 100ul 468 EUR

DcR1 Antibody

2299-002mg ProSci 0.02 mg 206.18 EUR
Description: DcR1 Antibody: Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors. TRAIL/Apo2L is a new member of the TNF family and induces apoptosis of a variety of tumor cell lines. DR4 and DR5 are the recently identified functional receptors for TRAIL. Two decoy receptors for TRAIL have been identified and designated DcR1/TRID/TRAIL-R3/LIT and DcR2/TRAIL-R4/TRUNDD. DcR1 has extracellular TRAIL-binding domain but lacks intracellular signaling domain. It is a glycophospholipid-anchored cell surface protein. DcR1 transcripts are expressed in many normal human tissues but not in most cancer cell lines. Overexpression of DcR1 did not induce apoptosis, but attenuated TRAIL-induced apoptosis.

DcR1 Antibody

2299-01mg ProSci 0.1 mg 523.7 EUR
Description: DcR1 Antibody: Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors. TRAIL/Apo2L is a new member of the TNF family and induces apoptosis of a variety of tumor cell lines. DR4 and DR5 are the recently identified functional receptors for TRAIL. Two decoy receptors for TRAIL have been identified and designated DcR1/TRID/TRAIL-R3/LIT and DcR2/TRAIL-R4/TRUNDD. DcR1 has extracellular TRAIL-binding domain but lacks intracellular signaling domain. It is a glycophospholipid-anchored cell surface protein. DcR1 transcripts are expressed in many normal human tissues but not in most cancer cell lines. Overexpression of DcR1 did not induce apoptosis, but attenuated TRAIL-induced apoptosis.

DCR3 Antibody

E38PA6111 EnoGene 100ul 225 EUR
Description: Available in various conjugation types.

DcR3 Antibody

E300315 EnoGene 100ug 275 EUR
Description: Available in various conjugation types.

DcR1 Antibody

GWB-7FB943 GenWay Biotech 0.5 ml Ask for price

DcR3 Antibody

GWB-F69AFD GenWay Biotech 0.05 mg Ask for price

DcR1 Antibody

MBS9412263-01mL MyBiosource 0.1mL 495 EUR

DcR1 Antibody

MBS9412263-5x01mL MyBiosource 5x0.1mL 2075 EUR

DcR3 Antibody

MBS9409571-01mL MyBiosource 0.1mL 495 EUR

DcR3 Antibody

MBS9409571-5x01mL MyBiosource 5x0.1mL 2075 EUR

DcR1 Antibody

MBS9406958-01mL MyBiosource 0.1mL 495 EUR

DcR1 Antibody

MBS9406958-5x01mL MyBiosource 5x0.1mL 2075 EUR

DCR3 Antibody

MBS8583800-01mL MyBiosource 0.1mL 305 EUR

DCR3 Antibody

MBS8583800-01mLAF405L MyBiosource 0.1mL(AF405L) 465 EUR

DCR3 Antibody

MBS8583800-01mLAF405S MyBiosource 0.1mL(AF405S) 465 EUR

DCR3 Antibody

MBS8583800-01mLAF610 MyBiosource 0.1mL(AF610) 465 EUR
In this Review, we talk about the proof supporting the strikingly distinct allele-dependent scientific phenotypes noticed in carriers of such gene mutations and its affect on the wider area of neurodegeneration.
Back to top